Bayer elige New Albany para su planta farmacéutica de $2.2 mil millones de dólares.

New Albany’s life sciences streak just got longer.

On Oct. 2, Bayer announced it will build a $2.2 billion pharmaceutical manufacturing plant in the New Albany International Business Park. The project is expected to put roughly 1,500 union construction workers on the job and create about 600 permanent positions once it opens.

Regional building trades leaders believe the work will go union, which means the project is expected to create work for Insulators Local 50 members. 

State officials, meanwhile, are calling it one of the largest direct investments by a German company in Ohio history.

El anuncio

Ohio Gov. Mike DeWine joined Bayer and JobsOhio to unveil the German company’s plans.

“Bayer is a globally respected life sciences company that could have chosen to build this new facility anywhere in the United States — and it chose Ohio,” DeWine said. “This project firmly solidifies Ohio’s place among global biomanufacturing leaders as a destination for life sciences investment.”

According to Columbus Business First, Bayer plans to buy 200 acres on Ganton Parkway, south of the Beech Road interchange with Route 161 and near AMGEN. The company expects to break ground next summer, with hiring beginning next year. Salaries for engineers, technicians, and others are expected to exceed $100,000 a year. The outlet also reported that the plant will be Bayer’s first pharmaceutical manufacturing facility in the United States.

What’s Being Built

Bayer is planning a flexible, modular campus that combines drug substance (active pharmaceutical ingredient) and drug product (finished prescription drug) manufacturing, using advanced digital and automation technology. The campus will support a portfolio focused on oncology, cardiovascular and renal care.

The first module, dedicated to drug substance manufacturing, is expected to open in 2031, with a second module for drug product manufacturing to follow in 2034. 

The site will complement Bayer’s U.S. pharmaceuticals headquarters in: 

  • Whippany, N.J.,
  • Pittsburgh
  • Berkeley, Calif.
  • Cambridge, Mass.
  • Research Triangle Park, N.C.
  • San Diego

Sebastian Guth, Global COO of Bayer Pharmaceuticals and President of Bayer U.S., told Columbus Business First why the company landed in Ohio.

“When we looked across the country for the right location, Ohio stood out,” Guth said. “Ohio offers a growing life science ecosystem: a strong, vibrant industry and access to a talented workforce that is ready to help shape the future of pharmaceutical manufacturing.”

Bayer CEO Bill Anderson tied the project to the company’s broader push in its largest pharmaceuticals market.

“Bayer has long seen the United States as a key manufacturing base and innovation hub,” Anderson said. “This landmark investment underscores our commitment. The new site will be home to manufacturing expertise and a skilled workforce that will strengthen our ability to deliver innovative, high-quality medicines to patients both in the United States and abroad.”

Workforce Readiness Played a Big Role

State and local officials said workforce readiness was central to landing the plant. Bayer will draw on the Ohio Life Science Training Center, now under construction and scheduled to open next summer, to train Ohioans as biomanufacturing operators and technicians. JobsOhio is investing up to $30 million in the center, alongside nearly $8 million from the city of New Albany, the state, and The New Albany Company, bringing the facility’s cost to nearly $38 million. Columbus State Community College is also part of the effort.

The investment came after Ohio lost a bid for another project to North Carolina, according to Columbus Business First. Construction on the 34,000-square-foot building on Walton Parkway is scheduled to begin in November, and the first trainees are expected to earn certificates the following fall.

“Bayer didn’t just choose a site. It chose a workforce,” said JobsOhio President and CEO J.P. Nauseef. “The Ohio Life Science Training Center exists to prepare Ohioans for careers in STEM, and it’s already paying off.”

Joining a Growing Life Sciences Cluster

Bayer joins a cluster of life sciences employers in the New Albany business park that includes Amgen, Hims & Hers, American Regent and Pharmavite. New Albany Mayor Sloan Spalding said the industry now employs 18,000 people across Central Ohio and 64,000 statewide.

Those companies also operate within the Ohio Discovery Corridor, which connects nine world-class medical and research facilities and leading academic institutions, with access to 39,000 annual STEM graduates and a $1 billion annual NIH-funded research engine.

Bayer plans to pursue a Job Creation Tax Credit from the Ohio Department of Development and assistance from JobsOhio. Details should be made public after a final agreement is signed. Columbus Business First reported the company would also seek a property tax abatement under a Community Reinvestment Area in the city, which would create an income tax revenue-sharing agreement with local schools.

Guth said the U.S. is Bayer’s fastest-growing pharmaceuticals market. The company employed about 88,000 people worldwide and reported sales of 45.6 billion euros (just over $51 billion) in fiscal year 2025.

Qué significa para los miembros del Local 50

Between fast, high-quality workforce training and a union construction workforce with a proven track record on life sciences facilities, New Albany is becoming the place where pharmaceutical companies want to build. With regional building trades leaders expecting the Bayer work to go union, Insulators Local 50 members can look forward to a long runway of specialized work on a $2.2 billion, multi-module buildout.

Are you an experienced insulator looking to get in on projects like these? Visit insulators50.com/experienced-insulators to learn how to become a member of Insulators Local 50.

Entradas recientes

Categoría

es_MXSpanish